Iovance Biotherapeutics Inc. buy Truist Financial Co.
Start price
03.03.25
/
50%
€3.84
Target price
03.03.26
€14.29
Performance (%)
-17.77%
End price
04.03.26
€3.16
Summary
This prediction ended on 04.03.26 with a price of €3.16. The price of Iovance Biotherapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.77%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 4.416% | 4.416% | 133.529% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Truist Financial Co. from $25.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.20
27.12.23
27.12.23
€15.35
27.12.24
27.12.24
12.30%
28.12.24
28.12.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.09
15.09.23
15.09.23
€15.92
15.09.24
15.09.24
76.82%
16.09.24
16.09.24